Geron Corporation (GERN) financial statements (2022 and earlier)

Company profile

Business Address 919 EAST HILLSDALE BOULEVARD
FOSTER CITY, CA 94404
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18419613916395115114
Cash and cash equivalents35101411161321
Short-term investments1491861261537810293
Restricted cash and investments0000000
Receivables2111001
Prepaid expense   1111
Other undisclosed current assets121    
Total current assets:18720014216696116116
Noncurrent Assets
Operating lease, right-of-use asset552
Property, plant and equipment1100000
Long-term investments and receivables29632019141433
Long-term investments29632019141433
Other noncurrent assets   1   
Other undisclosed noncurrent assets521    
Total noncurrent assets:39712419141433
TOTAL ASSETS:226271166185110130149
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4530145554
Accounts payable7711100
Accrued liabilities301581111
Employee-related liabilities8853333
Debt  0    
Restructuring reserve      0
Other undisclosed current liabilities11143232
Total current liabilities:4631288787
Noncurrent Liabilities
Long-term debt and lease obligation54292    
Long-term debt, excluding current maturities5024     
Operating lease, liability452
Other undisclosed noncurrent liabilities(4)(5)     
Total noncurrent liabilities:54292    
Total liabilities:10060308787
Stockholders' equity
Stockholders' equity attributable to parent126211135178104122142
Common stock0000000
Additional paid in capital1,3981,3661,2151,1891,0901,0801,071
Accumulated other comprehensive income (loss)(0)00(0)(0)(0)(0)
Accumulated deficit(1,272)(1,156)(1,080)(1,011)(986)(958)(928)
Total stockholders' equity:126211135178104122142
TOTAL LIABILITIES AND EQUITY:226271166185110130149

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues10011636
Revenue, net  35
Gross profit:10011636
Operating expenses(115)(77)(73)(32)(30)(37)(37)
Operating loss:(114)(77)(73)(31)(29)(31)(1)
Nonoperating income (expense)22(0)(0)(0)(0)(0)
Investment income, nonoperating12     
Other nonoperating income (expense)10(0)(0)(0)(0)(0)
Interest and debt expense(4)(1)     
Loss before gain (loss) on sale of properties:(116)(76)(73)(31)(29)(31)(1)
Other undisclosed net income 044   
Net loss:(116)(76)(69)(27)(29)(31)(1)
Other undisclosed net income attributable to parent    111
Net income (loss) available to common stockholders, diluted:(116)(76)(69)(27)(28)(30)0

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(116)(76)(69)(27)(29)(31)(1)
Other comprehensive income (loss)(0)(0)00   
Comprehensive loss:(116)(76)(68)(27)(29)(31)(1)
Other undisclosed comprehensive income, net of tax, attributable to parent    111
Comprehensive loss, net of tax, attributable to parent:(116)(76)(68)(27)(28)(29)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: